With congressmen clamoring to investigate whether drug manufacturers are inflating prices, a pair of Arkansas business leaders Thursday joined Democratic Rep. Marion Berry to advocate changes in prescription pricing in health-care legislation.
Subscribers must LOG-IN to read this full story.
Monthly and yearly online subscriptions are available starting at only $5.95. Access is free for print subscribers. Click here to see rates and register.
Front Section, Pages 8 on 11/20/2009
Comments
To report abuse or misuse of this area please hit the "Suggest Removal" link in the comment to alert our online managers. Please read our comment policy.
aimee says...
Medicare Part D was supposed to have a "trigger" (like some keep discussing for the public option) to keep prices down, but since 2003 it has never "kicked in"... The reason for this is that the pharmaceutical companies can "play" with their prices to make sure that it NEVER kicks in...
We need to let Health and Human Services bid on prescription drugs on behalf of ALL Americans... THIS is the only way to lower the cost of prescription drugs... Canada does it on behalf of all Canadians but, here, we only talk being allowed to BUY from Canada...??? Why can't our government negotiate drug prices here at home...??? This is the only logical thing to do, but it is fought tooth and nail by Big Pharma.. Let our Congressional delegation know that this is what we want and need..!!!
November 20, 2009 at 10:33 a.m. ( permalink | suggest removal )
Registration is required to make comments. Click here to LOGIN.
You can register for FREE to post comments and receive alerts.